Condition
Stage IIIC Lung Cancer AJCC v8 clinical trials and research
As of November 12, 2026, Find a Trial lists 10 Stage IIIC Lung Cancer AJCC v8 clinical trials that are recruiting, in United States. By phase: Phase 2 (4), Phase 1 (2), Phase 1/2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 1Country
Newest Stage IIIC Lung Cancer AJCC v8 clinical trials
All recruiting trials (10)
-
Combining chemotherapy with immunotherapy for older adults with advanced lung cancer
This study is testing if adding chemotherapy to immunotherapy can help older adults with advanced lung cancer live longer and feel better compared to just using immunotherapy alone.
-
Combining SX-682 and Pembrolizumab for Advanced Lung Cancer Treatment
This study is testing if a new oral medication called SX-682, when combined with the IV drug pembrolizumab, can help people with advanced lung cancer feel better and improve their treatment outcomes.
-
Personalized vaccine combined with pembrolizumab for advanced solid tumors
This study is testing a new personalized cancer vaccine combined with pembrolizumab to see if it helps people with advanced solid tumors fight their cancer better.
-
Using papaverine with chemoradiation to treat advanced non-small cell lung cancer
This study is testing the best dose of papaverine combined with chemotherapy and radiation to see if it helps people with advanced non-small cell lung cancer live longer and control their tumors better.
-
Assessing heart health in lung cancer patients receiving personalized chemoradiation
This study is testing how personalized chemoradiation treatment for lung cancer affects heart health in patients and if adjusting the treatment can help reduce heart disease risk.
-
Combining local therapy and durvalumab for advanced lung cancer after initial treatment
This study is testing whether combining local treatments like surgery or radiation with the immunotherapy durvalumab can help people with advanced lung cancer live longer and feel better after their initial treatment.
-
Using canakinumab to prevent lung cancer in high-risk patients
This study is testing if a medication called canakinumab can help prevent lung cancer in people who have high-risk lung nodules.
-
Avapritinib for treating advanced solid tumors with specific mutations
This study is testing if a new drug called avapritinib can help people with advanced solid tumors that have specific mutations feel better and live longer after other treatments haven't worked.
-
Yoga intervention to improve physical performance and quality of life for cancer patients and their caregivers
This study tests whether a yoga program can help improve physical performance and quality of life for cancer patients and their caregivers during radiotherapy.
-
Exploring gut microbiome and fecal transplant effects on GI issues in cancer patients
This study is testing how the gut bacteria affect stomach issues in cancer patients receiving certain treatments and whether a stool transplant can help relieve those problems.
Related topics
Quick answers
How many Stage IIIC Lung Cancer AJCC v8 clinical trials are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 1: 2, Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.